Parkin larvae bring researchers closer to solving Parkinson's disease puzzle
January 16, 2012 in Neuroscience(Medical Xpress) -- Scientists at the University of York have made a significant step forward in isolating the cause of Parkinsons disease in younger adults.
Research by a team in the Universitys Department of Biology found evidence that movement disorders, including tremor and slowness of movement (bradykinesia), associated with Parkinsons disease (PD) may be due to a defect in energy production in the nervous system. The advance may help to identify young adults who may be susceptible to the disease.
Parkinsons, the second most common form of neurodegenerative disease, principally affects people aged over 60, but some forms known as juvenile PD usually start in the 30-40 age group. One in 20 people diagnosed with Parkinson's are under 40 and such early onset PD is often inherited. Previous research has identified the genes which cause the disease and found them to be linked in a common pathway to failure of the mitochondria the power source within each cell.
In the latest research, part-funded by leading research charity Parkinsons UK and published in Human Molecular Genetics, scientists at York studied the effect that parkin, one of the genes which cause juvenile PD, has on the larva of the fruit fly, Drosophila.
They discovered that parkin faithfully models the locomotory defects of PD with a marked reduction in speed, and slower muscle contractions, reminiscent of bradykinesia.
Dr Chris Elliott, who led the study, said: Our experimental evidence confirmed that this was due to a defect in the nervous system. This was important because previous work had suggested a big impact on the muscles, but PD is associated with neuronal failure.
The research team, which included undergraduate and postgraduate students, found that oxygen consumption and the production of ATP (the chief supply of energy inside cells) were drastically reduced. In response, lactate was increased.
The researchers also discovered that parkin larvae showed oxidative stress due to high levels of reactive oxygen species (ROS; also known as free radicals, such as hydrogen peroxide) which have been suggested as a key component of PD. The study suggested that relieving the ROS had only a marginal effect on mitigating slowed locomotion.
Dr Elliott added: These findings show drastic failure in energy production by parkin larvae, and suggest that biochemicals related to lactate may be worth investigating as biomarkers for the progress of PD.
We believe that the larval bradykinesia is a consequence of neuronal energy deficit, which leads to failure in neural communication. Oxidative stress is a consequence, rather than cause, of PD.
Dr Kieran Breen, Director of Research and Innovation at Parkinsons UK, comments:
This study shows just how vital models like the fruit fly are in helping us understand what happens to the nerve cells that are affected in Parkinsons.
We already knew that mitochondria were important in Parkinsons but this research suggests that mitochondrial problems may be the root cause of the problems that lead to nerve cell death.
So finding ways to protect and enhance the mitochondria may be the key to treatments that can slow or even stop Parkinsons in its tracks.
More information: Amanda Vincent, Laura Briggs, Griff F.J. Chatwin, Elizabeth Emery, Rose Tomlins, Matt Oswald, C. Adam Middleton, Gareth J.O. Evans, Sean T. Sweeney and Christopher J.H. Elliot, parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress, Hum. Mol. Genet. (2012) doi: 10.1093/hmg/ddr609 , First published online: January 3, 2012.
Journal reference:
Human Molecular Genetics
Provided by University of York
-
Innovative new strategy to treat Parkinson's disease
Dec 19, 2011 |
not rated yet |
0
-
New research helps explain genetics of Parkinson's disease
Nov 24, 2008 |
not rated yet |
0
-
New discovery in Parkinson's research
Nov 24, 2010 |
not rated yet |
0
-
Reprogramming brain cells important first step for new Parkinson's therapy, study finds
Dec 13, 2011 |
not rated yet |
0
-
New insight into Parkinson's disease
Apr 19, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
17 hours ago
-
Popping/Cracked sternum.
21 hours ago
-
Which Mental Illness Encompasses This Problem?
22 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Neuroscience
May 25, 2012 |
not rated yet |
0
|
Persistent sensory experience is good for aging brain
Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Boundary stops molecule right where it needs to be
A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.
Neuroscience
May 24, 2012 |
not rated yet |
0
|
Locating ground zero: How the brain's emergency workers find the disaster area
Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. ...
Neuroscience
May 24, 2012 |
5 / 5 (2) |
0
|
Genetic 'reset switch' enables signaling pathway to induce multiple developmental outcomes for olfactory neurons
Within the nervous system, a handful of signaling pathways modulate development of a cornucopia of different neuronal subtypes. Even small alterations in neuron differentiation pathways can disrupt subsequent ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.